nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2B6—Sorafenib—thyroid cancer	0.195	0.242	CbGbCtD
Diphenhydramine—CYP2C19—Sorafenib—thyroid cancer	0.124	0.154	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—thyroid cancer	0.119	0.147	CbGbCtD
Diphenhydramine—CYP1A2—Sorafenib—thyroid cancer	0.115	0.142	CbGbCtD
Diphenhydramine—CYP2C9—Sorafenib—thyroid cancer	0.103	0.128	CbGbCtD
Diphenhydramine—CYP2D6—Sorafenib—thyroid cancer	0.0944	0.117	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—thyroid cancer	0.0573	0.0709	CbGbCtD
Diphenhydramine—Dysuria—Vandetanib—thyroid cancer	0.00399	0.0305	CcSEcCtD
Diphenhydramine—Pollakiuria—Vandetanib—thyroid cancer	0.00394	0.0301	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0039	0.0298	CcSEcCtD
Diphenhydramine—Vision blurred—Vandetanib—thyroid cancer	0.0028	0.0214	CcSEcCtD
Diphenhydramine—Tremor—Vandetanib—thyroid cancer	0.00279	0.0213	CcSEcCtD
Diphenhydramine—Convulsion—Vandetanib—thyroid cancer	0.00258	0.0197	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00252	0.0192	CcSEcCtD
Diphenhydramine—Dry mouth—Vandetanib—thyroid cancer	0.00248	0.0189	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00238	0.0182	CcSEcCtD
Diphenhydramine—Neuritis—Epirubicin—thyroid cancer	0.00227	0.0174	CcSEcCtD
Diphenhydramine—Insomnia—Vandetanib—thyroid cancer	0.0022	0.0168	CcSEcCtD
Diphenhydramine—Paraesthesia—Vandetanib—thyroid cancer	0.00218	0.0167	CcSEcCtD
Diphenhydramine—Tinnitus—Sorafenib—thyroid cancer	0.00215	0.0164	CcSEcCtD
Diphenhydramine—Dyspepsia—Vandetanib—thyroid cancer	0.00214	0.0163	CcSEcCtD
Diphenhydramine—Decreased appetite—Vandetanib—thyroid cancer	0.00211	0.0161	CcSEcCtD
Diphenhydramine—Neuritis—Doxorubicin—thyroid cancer	0.0021	0.0161	CcSEcCtD
Diphenhydramine—Fatigue—Vandetanib—thyroid cancer	0.00209	0.016	CcSEcCtD
Diphenhydramine—Constipation—Vandetanib—thyroid cancer	0.00208	0.0159	CcSEcCtD
Diphenhydramine—Asthenia—Vandetanib—thyroid cancer	0.00174	0.0133	CcSEcCtD
Diphenhydramine—Dry mouth—Sorafenib—thyroid cancer	0.00167	0.0128	CcSEcCtD
Diphenhydramine—Diarrhoea—Vandetanib—thyroid cancer	0.00166	0.0127	CcSEcCtD
Diphenhydramine—Dizziness—Vandetanib—thyroid cancer	0.00161	0.0123	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Sorafenib—thyroid cancer	0.0016	0.0122	CcSEcCtD
Diphenhydramine—Anorexia—Sorafenib—thyroid cancer	0.00156	0.0119	CcSEcCtD
Diphenhydramine—Vomiting—Vandetanib—thyroid cancer	0.00154	0.0118	CcSEcCtD
Diphenhydramine—Rash—Vandetanib—thyroid cancer	0.00153	0.0117	CcSEcCtD
Diphenhydramine—Dermatitis—Vandetanib—thyroid cancer	0.00153	0.0117	CcSEcCtD
Diphenhydramine—Headache—Vandetanib—thyroid cancer	0.00152	0.0116	CcSEcCtD
Diphenhydramine—Nausea—Vandetanib—thyroid cancer	0.00144	0.011	CcSEcCtD
Diphenhydramine—Dyspepsia—Sorafenib—thyroid cancer	0.00144	0.011	CcSEcCtD
Diphenhydramine—Decreased appetite—Sorafenib—thyroid cancer	0.00142	0.0109	CcSEcCtD
Diphenhydramine—Fatigue—Sorafenib—thyroid cancer	0.00141	0.0108	CcSEcCtD
Diphenhydramine—Photosensitivity—Epirubicin—thyroid cancer	0.0014	0.0107	CcSEcCtD
Diphenhydramine—Constipation—Sorafenib—thyroid cancer	0.0014	0.0107	CcSEcCtD
Diphenhydramine—Urticaria—Sorafenib—thyroid cancer	0.0013	0.00994	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—thyroid cancer	0.0013	0.00991	CcSEcCtD
Diphenhydramine—Diplopia—Epirubicin—thyroid cancer	0.00123	0.00941	CcSEcCtD
Diphenhydramine—Asthenia—Sorafenib—thyroid cancer	0.00117	0.00897	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—thyroid cancer	0.00114	0.0087	CcSEcCtD
Diphenhydramine—Diarrhoea—Sorafenib—thyroid cancer	0.00112	0.00856	CcSEcCtD
Diphenhydramine—Dizziness—Sorafenib—thyroid cancer	0.00108	0.00827	CcSEcCtD
Diphenhydramine—Vomiting—Sorafenib—thyroid cancer	0.00104	0.00795	CcSEcCtD
Diphenhydramine—Rash—Sorafenib—thyroid cancer	0.00103	0.00789	CcSEcCtD
Diphenhydramine—Dermatitis—Sorafenib—thyroid cancer	0.00103	0.00788	CcSEcCtD
Diphenhydramine—Headache—Sorafenib—thyroid cancer	0.00103	0.00784	CcSEcCtD
Diphenhydramine—Dysuria—Epirubicin—thyroid cancer	0.000995	0.0076	CcSEcCtD
Diphenhydramine—Pollakiuria—Epirubicin—thyroid cancer	0.000983	0.00751	CcSEcCtD
Diphenhydramine—Nausea—Sorafenib—thyroid cancer	0.000973	0.00743	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000971	0.00742	CcSEcCtD
Diphenhydramine—Drowsiness—Epirubicin—thyroid cancer	0.000949	0.00725	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00093	0.0071	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—thyroid cancer	0.000921	0.00703	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—thyroid cancer	0.00091	0.00695	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000899	0.00687	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—thyroid cancer	0.000886	0.00676	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—thyroid cancer	0.000878	0.00671	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000861	0.00657	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000819	0.00626	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—thyroid cancer	0.000794	0.00607	CcSEcCtD
Diphenhydramine—Chills—Epirubicin—thyroid cancer	0.000764	0.00584	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—thyroid cancer	0.000735	0.00561	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—thyroid cancer	0.000728	0.00556	CcSEcCtD
Diphenhydramine—Nervousness—Epirubicin—thyroid cancer	0.00072	0.0055	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—thyroid cancer	0.000707	0.0054	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—thyroid cancer	0.000699	0.00534	CcSEcCtD
Diphenhydramine—Agitation—Epirubicin—thyroid cancer	0.000681	0.00521	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—thyroid cancer	0.000673	0.00514	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—thyroid cancer	0.000666	0.00509	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—thyroid cancer	0.000666	0.00509	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—thyroid cancer	0.000655	0.00501	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—thyroid cancer	0.000647	0.00494	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—thyroid cancer	0.000643	0.00491	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—thyroid cancer	0.000631	0.00482	CcSEcCtD
Diphenhydramine—Dry mouth—Epirubicin—thyroid cancer	0.000617	0.00472	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—thyroid cancer	0.000616	0.00471	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—thyroid cancer	0.00061	0.00466	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—thyroid cancer	0.000606	0.00463	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—thyroid cancer	0.000595	0.00454	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000593	0.00453	CcSEcCtD
Diphenhydramine—Tachycardia—Epirubicin—thyroid cancer	0.000591	0.00451	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000585	0.00447	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—thyroid cancer	0.000577	0.00441	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—thyroid cancer	0.000571	0.00436	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—thyroid cancer	0.000566	0.00432	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—thyroid cancer	0.000565	0.00431	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000548	0.00419	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—thyroid cancer	0.000547	0.00418	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—thyroid cancer	0.000547	0.00417	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—thyroid cancer	0.000543	0.00415	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000541	0.00414	CcSEcCtD
Diphenhydramine—Somnolence—Epirubicin—thyroid cancer	0.000538	0.00411	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—thyroid cancer	0.000534	0.00408	CcSEcCtD
Diphenhydramine—Dyspepsia—Epirubicin—thyroid cancer	0.000533	0.00407	CcSEcCtD
Diphenhydramine—Decreased appetite—Epirubicin—thyroid cancer	0.000526	0.00402	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—thyroid cancer	0.000523	0.004	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—thyroid cancer	0.000522	0.00399	CcSEcCtD
Diphenhydramine—Constipation—Epirubicin—thyroid cancer	0.000518	0.00395	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—thyroid cancer	0.000506	0.00387	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—thyroid cancer	0.000503	0.00384	CcSEcCtD
Diphenhydramine—Feeling abnormal—Epirubicin—thyroid cancer	0.000499	0.00381	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—thyroid cancer	0.000498	0.0038	CcSEcCtD
Diphenhydramine—Dyspepsia—Doxorubicin—thyroid cancer	0.000493	0.00377	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—thyroid cancer	0.000487	0.00372	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—thyroid cancer	0.000483	0.00369	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—thyroid cancer	0.000481	0.00367	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—thyroid cancer	0.000479	0.00366	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000461	0.00352	CcSEcCtD
Diphenhydramine—Urticaria—Doxorubicin—thyroid cancer	0.000445	0.0034	CcSEcCtD
Diphenhydramine—Asthenia—Epirubicin—thyroid cancer	0.000434	0.00332	CcSEcCtD
Diphenhydramine—Diarrhoea—Epirubicin—thyroid cancer	0.000414	0.00316	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—thyroid cancer	0.000402	0.00307	CcSEcCtD
Diphenhydramine—Dizziness—Epirubicin—thyroid cancer	0.0004	0.00306	CcSEcCtD
Diphenhydramine—Vomiting—Epirubicin—thyroid cancer	0.000385	0.00294	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—thyroid cancer	0.000383	0.00293	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—thyroid cancer	0.000382	0.00291	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—thyroid cancer	0.000381	0.00291	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—thyroid cancer	0.000379	0.0029	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—thyroid cancer	0.00037	0.00283	CcSEcCtD
Diphenhydramine—Nausea—Epirubicin—thyroid cancer	0.000359	0.00275	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—thyroid cancer	0.000356	0.00272	CcSEcCtD
Diphenhydramine—Rash—Doxorubicin—thyroid cancer	0.000353	0.0027	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—thyroid cancer	0.000353	0.00269	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—thyroid cancer	0.000351	0.00268	CcSEcCtD
Diphenhydramine—Nausea—Doxorubicin—thyroid cancer	0.000333	0.00254	CcSEcCtD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000192	0.00314	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CALCB—thyroid cancer	0.000191	0.00312	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.000188	0.00307	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CALCB—thyroid cancer	0.000188	0.00307	CbGpPWpGaD
Diphenhydramine—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00018	0.00294	CbGpPWpGaD
Diphenhydramine—CYP2B6—Biological oxidations—RXRA—thyroid cancer	0.000178	0.00291	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MINPP1—thyroid cancer	0.000177	0.00289	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CALCB—thyroid cancer	0.000173	0.00283	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000172	0.00281	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—HPGD—thyroid cancer	0.000172	0.00281	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CALCB—thyroid cancer	0.000171	0.00279	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000166	0.00272	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MINPP1—thyroid cancer	0.000165	0.00269	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000165	0.00269	CbGpPWpGaD
Diphenhydramine—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000164	0.00268	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00016	0.00261	CbGpPWpGaD
Diphenhydramine—Oxaprozin—PTGS2—thyroid cancer	0.000159	0.402	CrCbGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000157	0.00257	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—TSHR—thyroid cancer	0.000156	0.00256	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—TSHR—thyroid cancer	0.000154	0.00252	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—NDUFA13—thyroid cancer	0.00015	0.00246	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.00015	0.00245	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000146	0.00239	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000143	0.00234	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—thyroid cancer	0.000142	0.00231	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CHST14—thyroid cancer	0.000141	0.00231	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NDUFA13—thyroid cancer	0.00014	0.00229	CbGpPWpGaD
Diphenhydramine—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00014	0.00229	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.00014	0.00228	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00014	0.00228	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00014	0.00228	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000138	0.00225	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CHST14—thyroid cancer	0.000137	0.00224	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000135	0.0022	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—PTCH1—thyroid cancer	0.000133	0.00217	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CHST14—thyroid cancer	0.000132	0.00215	CbGpPWpGaD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—AKT1—thyroid cancer	0.000132	0.00215	CbGpPWpGaD
Diphenhydramine—Fenoprofen—PTGS2—thyroid cancer	0.000131	0.332	CrCbGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000131	0.00214	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MINPP1—thyroid cancer	0.000131	0.00214	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—PTCH1—thyroid cancer	0.000131	0.00214	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000131	0.00213	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.00013	0.00213	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00013	0.00213	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000128	0.00209	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000124	0.00203	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000123	0.00201	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000122	0.002	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—SST—thyroid cancer	0.000122	0.00199	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—SST—thyroid cancer	0.00012	0.00196	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CALCA—thyroid cancer	0.000117	0.00191	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000117	0.0019	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CALCA—thyroid cancer	0.000115	0.00188	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—HPGD—thyroid cancer	0.000114	0.00186	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000112	0.00182	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	0.000111	0.00182	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—HPGD—thyroid cancer	0.000111	0.00181	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—HPGD—thyroid cancer	0.000106	0.00174	CbGpPWpGaD
Diphenhydramine—Phenylbutazone—PTGS2—thyroid cancer	0.000105	0.266	CrCbGaD
Diphenhydramine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000105	0.00172	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CHST14—thyroid cancer	0.000105	0.00171	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000105	0.00171	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CALCB—thyroid cancer	0.000102	0.00167	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CALCB—thyroid cancer	0.000101	0.00165	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—BRAF—thyroid cancer	0.000101	0.00164	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.0001	0.00164	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MINPP1—thyroid cancer	9.9e-05	0.00162	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—TPR—thyroid cancer	9.86e-05	0.00161	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.75e-05	0.00159	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TRIM33—thyroid cancer	9.71e-05	0.00159	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	9.7e-05	0.00159	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TRIM33—thyroid cancer	9.56e-05	0.00156	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—BRAF—thyroid cancer	9.37e-05	0.00153	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MINPP1—thyroid cancer	9.11e-05	0.00149	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MINPP1—thyroid cancer	9.03e-05	0.00147	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.97e-05	0.00147	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	8.9e-05	0.00145	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—TSHR—thyroid cancer	8.84e-05	0.00144	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.79e-05	0.00144	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—TSHR—thyroid cancer	8.7e-05	0.00142	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	8.53e-05	0.00139	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—HPGD—thyroid cancer	8.44e-05	0.00138	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	8.42e-05	0.00138	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.19e-05	0.00134	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—TSHR—thyroid cancer	8.03e-05	0.00131	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CHST14—thyroid cancer	7.91e-05	0.00129	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—TSHR—thyroid cancer	7.9e-05	0.00129	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PRKAR1A—thyroid cancer	7.9e-05	0.00129	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PRKAR1A—thyroid cancer	7.77e-05	0.00127	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	7.74e-05	0.00127	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MINPP1—thyroid cancer	7.71e-05	0.00126	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	7.68e-05	0.00125	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	7.66e-05	0.00125	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—SLC5A5—thyroid cancer	7.38e-05	0.00121	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CHST14—thyroid cancer	7.28e-05	0.00119	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CHST14—thyroid cancer	7.22e-05	0.00118	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—SST—thyroid cancer	6.88e-05	0.00112	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PTCH1—thyroid cancer	6.83e-05	0.00112	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—SST—thyroid cancer	6.77e-05	0.00111	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	6.74e-05	0.0011	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PTCH1—thyroid cancer	6.72e-05	0.0011	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CALCA—thyroid cancer	6.62e-05	0.00108	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	6.56e-05	0.00107	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TPR—thyroid cancer	6.55e-05	0.00107	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CALCA—thyroid cancer	6.51e-05	0.00106	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TCF7L1—thyroid cancer	6.48e-05	0.00106	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	6.44e-05	0.00105	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HPGD—thyroid cancer	6.38e-05	0.00104	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TCF7L1—thyroid cancer	6.38e-05	0.00104	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—TPR—thyroid cancer	6.35e-05	0.00104	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PRKAR1A—thyroid cancer	6.25e-05	0.00102	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—SST—thyroid cancer	6.24e-05	0.00102	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—RXRA—thyroid cancer	6.2e-05	0.00101	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CHST14—thyroid cancer	6.17e-05	0.00101	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—SST—thyroid cancer	6.14e-05	0.001	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TPR—thyroid cancer	6.1e-05	0.000997	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	6.03e-05	0.000986	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CALCA—thyroid cancer	6.01e-05	0.000982	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	6e-05	0.000981	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CALCA—thyroid cancer	5.91e-05	0.000966	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HPGD—thyroid cancer	5.87e-05	0.000959	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HPGD—thyroid cancer	5.82e-05	0.00095	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	5.8e-05	0.000948	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.67e-05	0.000926	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.62e-05	0.000919	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CDK1—thyroid cancer	5.44e-05	0.000889	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CDK1—thyroid cancer	5.35e-05	0.000875	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.17e-05	0.000845	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HPGD—thyroid cancer	4.97e-05	0.000812	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	4.93e-05	0.000806	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	4.9e-05	0.000801	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TPR—thyroid cancer	4.85e-05	0.000792	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	4.77e-05	0.000779	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SLC5A5—thyroid cancer	4.76e-05	0.000777	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TSHR—thyroid cancer	4.74e-05	0.000775	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.72e-05	0.000771	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TSHR—thyroid cancer	4.67e-05	0.000763	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRKAR1A—thyroid cancer	4.67e-05	0.000762	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—HRAS—thyroid cancer	4.62e-05	0.000755	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKAR1A—thyroid cancer	4.59e-05	0.00075	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SLC5A5—thyroid cancer	4.57e-05	0.000746	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MEN1—thyroid cancer	4.46e-05	0.000729	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.46e-05	0.000728	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MEN1—thyroid cancer	4.39e-05	0.000717	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—HRAS—thyroid cancer	4.31e-05	0.000704	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—RXRA—thyroid cancer	4.12e-05	0.000673	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTCH1—thyroid cancer	4.03e-05	0.000659	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.03e-05	0.000659	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—RXRA—thyroid cancer	4e-05	0.000653	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTCH1—thyroid cancer	3.97e-05	0.000648	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PPARG—thyroid cancer	3.92e-05	0.00064	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.89e-05	0.000635	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—RXRA—thyroid cancer	3.84e-05	0.000627	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SST—thyroid cancer	3.69e-05	0.000603	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TPR—thyroid cancer	3.66e-05	0.000599	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	3.63e-05	0.000593	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SST—thyroid cancer	3.63e-05	0.000593	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.6e-05	0.000589	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CALCA—thyroid cancer	3.55e-05	0.00058	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CALCA—thyroid cancer	3.49e-05	0.000571	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TPR—thyroid cancer	3.37e-05	0.000551	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TPR—thyroid cancer	3.34e-05	0.000546	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	3.32e-05	0.000542	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	3.29e-05	0.000537	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.27e-05	0.000534	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDK1—thyroid cancer	3.21e-05	0.000525	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDK1—thyroid cancer	3.16e-05	0.000517	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—thyroid cancer	3.08e-05	0.000503	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—RXRA—thyroid cancer	3.05e-05	0.000498	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.98e-05	0.000487	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TPR—thyroid cancer	2.85e-05	0.000466	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.81e-05	0.000459	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.74e-05	0.000448	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTEN—thyroid cancer	2.69e-05	0.000439	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—thyroid cancer	2.6e-05	0.000425	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRG1—thyroid cancer	2.58e-05	0.000422	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.57e-05	0.00042	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.55e-05	0.000416	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRG1—thyroid cancer	2.54e-05	0.000415	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—thyroid cancer	2.52e-05	0.000412	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.52e-05	0.000412	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.5e-05	0.000409	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—thyroid cancer	2.42e-05	0.000396	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.34e-05	0.000383	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—thyroid cancer	2.32e-05	0.000378	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—RXRA—thyroid cancer	2.3e-05	0.000377	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—thyroid cancer	2.28e-05	0.000372	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.24e-05	0.000366	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—thyroid cancer	2.22e-05	0.000362	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	2.18e-05	0.000356	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.14e-05	0.000349	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RXRA—thyroid cancer	2.12e-05	0.000346	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RXRA—thyroid cancer	2.1e-05	0.000343	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—thyroid cancer	2.04e-05	0.000334	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.04e-05	0.000334	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2e-05	0.000327	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—thyroid cancer	1.99e-05	0.000324	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.95e-05	0.000319	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—thyroid cancer	1.93e-05	0.000315	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	1.92e-05	0.000314	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.91e-05	0.000311	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.83e-05	0.0003	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	1.8e-05	0.000295	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.8e-05	0.000293	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—thyroid cancer	1.78e-05	0.000291	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.75e-05	0.000285	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—thyroid cancer	1.73e-05	0.000283	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.68e-05	0.000274	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—thyroid cancer	1.66e-05	0.000272	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	1.65e-05	0.00027	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—thyroid cancer	1.55e-05	0.000253	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.51e-05	0.000247	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.46e-05	0.000238	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.43e-05	0.000233	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	1.4e-05	0.00023	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.39e-05	0.000227	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	1.37e-05	0.000223	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.34e-05	0.000219	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.34e-05	0.000219	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—thyroid cancer	1.33e-05	0.000217	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—thyroid cancer	1.32e-05	0.000216	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	1.32e-05	0.000215	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.29e-05	0.000211	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	1.27e-05	0.000208	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.26e-05	0.000206	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	1.24e-05	0.000203	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.15e-05	0.000188	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.14e-05	0.000187	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	1.13e-05	0.000185	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—thyroid cancer	1.13e-05	0.000185	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.05e-05	0.000172	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.04e-05	0.000171	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—thyroid cancer	1.03e-05	0.000168	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—thyroid cancer	9.98e-06	0.000163	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—thyroid cancer	9.98e-06	0.000163	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—thyroid cancer	9.92e-06	0.000162	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	9.76e-06	0.00016	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—thyroid cancer	9.58e-06	0.000157	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—thyroid cancer	9.18e-06	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—thyroid cancer	9.1e-06	0.000149	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—thyroid cancer	8.92e-06	0.000146	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—thyroid cancer	8.82e-06	0.000144	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—thyroid cancer	8.68e-06	0.000142	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—thyroid cancer	8.43e-06	0.000138	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	8.3e-06	0.000136	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—thyroid cancer	7.78e-06	0.000127	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—thyroid cancer	7.61e-06	0.000124	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—thyroid cancer	7.45e-06	0.000122	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	7.33e-06	0.00012	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—thyroid cancer	5.75e-06	9.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—thyroid cancer	5.29e-06	8.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—thyroid cancer	5.25e-06	8.57e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—thyroid cancer	4.48e-06	7.32e-05	CbGpPWpGaD
